Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials
Edoardo Mannucci, Besmir Nreu, Chiara Montereggi, Benedetta Ragghianti, Marco Gallo, Andrea Giaccari, Matteo Monami, Edoardo Mannucci, Riccardo Candido, Basilio Pintaudi, Giovanni Targher, Lina Delle Monache, Marco Gallo, Andrea Giaccari, Maria Luisa Masini, Fulvia Mazzone, Gerardo Medea, Marina Trento, Giuseppe Turchetti
Topics & Concepts
SaxagliptinAlogliptinSitagliptinMedicineVildagliptinLinagliptinHeart failureInternal medicineDipeptidyl peptidase-4 inhibitorRandomized controlled trialOdds ratioMaceMeta-analysisType 2 diabetesSitagliptin PhosphateDiabetes mellitusEndocrinologyMyocardial infarctionConventional PCIDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisHeart Failure Treatment and Management